Show simple item record

dc.contributor.authorJones, Gareth T.
dc.contributor.authorMacfarlane, Gary J.
dc.contributor.authorForrest Keenan, Karen
dc.contributor.authorMcNamee, Paul
dc.contributor.authorNeilson, Aileen R.
dc.contributor.authorSiebert, Stefan
dc.contributor.authorBurden, A. David
dc.contributor.authorKay, Lesley
dc.contributor.authorHelliwell, Philip S.
dc.date.accessioned2021-05-18T19:16:01Z
dc.date.available2021-05-18T19:16:01Z
dc.date.issued2021-05-17
dc.identifier.citationJones , G T , Macfarlane , G J , Forrest Keenan , K , McNamee , P , Neilson , A R , Siebert , S , Burden , A D , Kay , L & Helliwell , P S 2021 , ' The BSR-PsA : study protocol for the British Society for Rheumatology psoriatic arthritis register ' , BMC Rheumatology , vol. 5 , no. 1 , 19 . https://doi.org/10.1186/s41927-021-00189-0en
dc.identifier.issn2520-1026
dc.identifier.otherPURE: 193454170
dc.identifier.otherPURE UUID: 70d103e4-b61d-46bb-8e32-fcf65d749863
dc.identifier.otherJisc: 637de0da146f4b6988fb55c6b2984d50
dc.identifier.otherpublisher-id: s41927-021-00189-0
dc.identifier.othermanuscript: 189
dc.identifier.otherORCID: /0000-0003-2322-3314/work/94083583
dc.identifier.otherORCID: /0000-0003-0016-7591/work/94084262
dc.identifier.otherPubMed: 33993880
dc.identifier.otherScopus: 85105872607
dc.identifier.urihttps://hdl.handle.net/2164/16488
dc.descriptionAcknowledgements We acknowledge contribution of BSR-PsA study staff, under the supervision of KFK: Maureen Heddle, Barry Morris, Jonathan Lock and Jane Brady. We also acknowledge the support from the Centre for Healthcare Randomised Trials (CHaRT) at the University of Aberdeen, especially Mark Forrest and Brian Taylor, for database and IT support. We would like to thank Professor Iain McInnes from the University of Glasgow, and our International Advisory Committee (Professors Merete Hetland, Oliver Fitzgerald and Philip Mease), for their comments when developing the protocol and for advice in harmonising data collection with other international studies, and the staff at the British Society for Rheumatology, in particular Alan Roach, Ross Matthews, Chris Hiley and Debbie MacDonald. Finally, we are indebted to the staff at all participating NHS trusts (details of which are available from www.abdn.ac.uk/bsr-psa) and especially the NIHR Clinical Research Network research nurses for their assistance with participant recruitment and data collection. Funding The BSR-PsA is funded by the BSR as part of its rheumatology registers portfolio and, in turn, receives funding for this from pharmaceutical companies. At the time of publication, only Amgen (previously Celgene) have contributed to the funding of the BSR-PsA. Pharmaceutical companies providing funds to BSR do not participant in the conduct or oversight of the study. However, they do receive advance notice of publications on which they are able to comment. Companies contributing to the funding of the register can request anonymised data on clinically confirmed serious adverse events and some events of special interest (e.g. pregnancy) among participants prescribed the specific bDMARD or tsDMARD agents that they manufacture. Other than this information, they do not have access to any raw data. They may, however, request specific analyses to be performed, for which a pre-specific analysis plan is discussed, and additional funds are provided.en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofBMC Rheumatologyen
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectStudy Protocolen
dc.subjectClinical rheumatologyen
dc.subjectPsoriatic arthritisen
dc.subjectTargeted therapyen
dc.subjectBiologicsen
dc.subjectBiosimilarsen
dc.subjectRegistryen
dc.subjectReal world evidenceen
dc.subjectR Medicineen
dc.subjectOtheren
dc.subject.lccRen
dc.titleThe BSR-PsA : study protocol for the British Society for Rheumatology psoriatic arthritis registeren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s41927-021-00189-0
dc.identifier.vol5en
dc.identifier.iss1en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record